RESEARCH LIBRARY

Journal of Veterinary Medical Education 2018 45:3, 381-387

This study uses item response data from the November–December 2014 and April 2015 NAVLE administrations (n =5,292), to conduct timing analyses comparing performance across several examinee subgroups. The results provide evidence that conditions were sufficient for most examinees, thereby supporting the current time limits. For the relatively few examinees who may have been impacted, results suggest the cause is not a bias with the test but rather the effect of poor pacing behavior combined with knowledge deficits.

Qual Life Res 27, 1711–1720 (2018)

The US Food and Drug Administration (FDA), as part of its regulatory mission, is charged with determining whether a clinical outcome assessment (COA) is “fit for purpose” when used in clinical trials to support drug approval and product labeling. This paper provides a review (and some commentary) on the current state of affairs in COA development/evaluation/use with a focus on one aspect: How do you know you are measuring the right thing? In the psychometric literature, this concept is referred to broadly as validity and has itself evolved over many years of research and application.